[1] Brun JL,Feyler A,Chne G,et al. Long-term results and prognostic factors in patients with epithelial ovarian cancer[J]. Gynecol Oncol,2000,78(1):21-27.
[2] Ferrandina G,Scambia G,Legge F,et al. Ovarian cancer patients withnode-positive-onlystage Ⅲc disease have a more favorable outcome than stage ⅢA/B[J]. Gynecol Oncol,2007,107(1):154-156.
[3] Berek JS. Lymph node-positive stage Ⅲ C ovarian cancer: a separate entity[J]. Int J Gynecol Cancer,2009,19(2):18-20.
[4] Baek SJ,Park JY,Kim DY,et al. Stage Ⅲ c epithelial ovarian cancer classified solely by lymph node metastasis has a more favorable prognosis than other types of stage Ⅲc epithelial ovarian cancer[J]. J Gynecol Oncol,2008,19(4):223-238.
[5] Chi DS,Liao JB,Leon LF,et al. Identification of prognostic factors in advanced epithelial ovarian carcinoma[J]. Gynecol Oncol,2001,82(3):532-537.
[6] Bristow RE,Tomacruz RS,Armstrong DK,et al. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era:a meta-analysis[J]. J Clin Oncol,2002,20(5):1248-1259.
[7] di Re F,Baiocchi G,Fontanelli R,et al. Systematic pelvic and paraaortic lymphadenectomy for advanced ovariancancer:prognostic significance of node metastases[J]. Gynecol Oncol,1996,62(3):360-365.